This patent covers IL-3 and various deviations of it, in combination with other hematopoietic stem cell stimulatory cytokines for acceleration of hematopoietic recovery after stem cell transplantation. This patent is useful in situations in which the stem cell dose administered may be relatively low, such as cord blood transplants given to adult recipients.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.